Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,052.98
(0.58%)
USD/AUD
0.62
0.08%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,130.43
(0.1%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%

Paradigm Biopharmaceuticals (ASX: $PAR) completes $16 million capital raise

Paradigm Biopharmaceuticals secures funding


Paradigm Biopharmaceuticals (ASX:PAR), a company focused on drug development, has completed a capital raise of $16 million. This was achieved through the placement of 40 million shares at $0.40 each. The funds will be used for a Phase 3 clinical trial of their osteoarthritis treatment, injectable pentosan polysulfate sodium (iPPS), starting in Australia in Q1 2025 and expanding to the U.S. in Q2 2025.

Paradigm's pathway to osteoarthritis treatment


Paradigm Biopharmaceuticals has strategically raised $16 million to fund its upcoming Phase 3 clinical trial for osteoarthritis using injectable pentosan polysulfate sodium (iPPS). The trial is set to start in Australia in the first quarter of 2025 and expand to the U.S. in the following quarter. The company is committed to advancing this treatment, supported by feedback from regulatory bodies like the TGA and FDA, which have acknowledged its potential benefits. Paradigm's introduction of a Loyalty Option Incentive Program aims to further raise $63 million by early 2026. The company's plans include seeking non-dilutive funding through partnerships and licensing deals, ensuring a comprehensive approach to bringing iPPS to market. Paradigm's efforts reflect its dedication to enhancing shareholder value and addressing osteoarthritis' unmet medical needs.

Insights on Paradigm's strategic initiatives


The successful capital raise is a significant milestone for Paradigm as we advance our osteoarthritis treatment towards a pivotal Phase 3 trial. The funding secured will enable us to commence the trial in Australia and the U.S., which is a crucial step in our journey to address the unmet medical needs of osteoarthritis patients. Additionally, our Loyalty Option Incentive Program is designed to enhance shareholder value and potentially raise further capital to support our long-term goals.

PARADIGM BIOPHARMACEUTICALS LIMITED..
PAR | ASX | Health Care
0.375-0.015(-3.85%)
At close 24/12 (AEDT)
Market cap
$146.0M
Volume
879,001
DY Yield
PE Ratio
52 Week Range
0.165 - 0.61
1YR Return
N / A

0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions